Top Stories in Health: From Drug Battles to Bird Flu Alerts

The health sector sees dynamic developments: Warner Bros Discovery rejects a merger offer, Getinge exceeds profit estimates despite tariff challenges, Novo Nordisk's investor reshuffles its board, France escalates bird flu alerts, and Spain halts cattle exports amid a disease outbreak. Also, WeightWatchers partners with Amazon for drug delivery.

In a bustling week of health sector news, several stories make headlines. Warner Bros Discovery rejected a nearly $24 per share acquisition offer from Paramount Skydance, as told by insiders.

Swedish company Getinge managed to surpass quarterly profit expectations despite absorbing substantial U.S. tariff costs, propelled by strategic price increases and cost-saving measures. Meanwhile, Novo Nordisk's principal investor seeks control over the board, aiming to boost sales of its popular weight-loss drug Wegovy by refocusing on the U.S. market.

Bird flu has prompted an elevated alert level in France, mandating poultry to be kept indoors. Concurrently, Spain imposed a ban on live cattle exports due to the lumpy skin disease. Adding to these developments, WeightWatchers has teamed up with Amazon to streamline drug delivery for its members, causing its shares to surge.